St Cloud, February, 10th, 2010 –
M. Hugues Lecat has been appointed Chairman and Chief Executive Officer of the Management Board of the pharmaceutical company Ethypharm.
Hugues Lecat, 53, graduated from the Ecole Superieure de Commerce in Rouen and holds an MBA from INSEAD.
He has a vast experience in various functions such as finance, marketing, management in the Healthcare industry, and has held major positions with Medtronic, Rhone-Poulenc Rorer, Aventis, and Sanofi-aventis. More recently, he was Chief Executive Officer of Cooper, the pharmaceutical company specialized in OTC products.
Hugues Lecat, who succeeds to M. Olivier Thiberge, will carry on with the objective of making Ethypharm the worldwide privileged partner of pharmaceutical companies for the life cycle management of their drugs.
